U.S. Medical Fluoropolymers Market Size & Outlook, 2025-2033
Related Markets
U.S. medical fluoropolymers market highlights
- The U.S. medical fluoropolymers market generated a revenue of USD 189.8 million in 2024 and is expected to reach USD 422.3 million by 2033.
- The U.S. market is expected to grow at a CAGR of 9.3% from 2025 to 2033.
- In terms of segment, polytetrafluoroethylene (ptfe) was the largest revenue generating product in 2024.
- Ethylene Tetrafluoroethylene (ETFE) is the most lucrative product segment registering the fastest growth during the forecast period.
Medical fluoropolymers market data book summary
| Market revenue in 2024 | USD 189.8 million |
| Market revenue in 2033 | USD 422.3 million |
| Growth rate | 9.3% (CAGR from 2025 to 2033) |
| Largest segment | Polytetrafluoroethylene (ptfe) |
| Fastest growing segment | Ethylene Tetrafluoroethylene (ETFE) |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Ethylene Tetrafluoroethylene (ETFE), Polytetrafluoroethylene (PTFE), Polyvinylidene Fluoride (PVDF), Fluoroelastomers |
| Key market players worldwide | Daikin Industries Ltd, The Chemours Co, Solvay SA, Arkema SA, Dongyue Group Ltd, Compagnie de Saint-Gobain SA, W.L. Gore & Associates, Hitachi Ltd, Adtech Polymer Engineering, Holscot Fluoropolymers |
Other key industry trends
- In terms of revenue, U.S. accounted for 33.5% of the global medical fluoropolymers market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In North America, U.S. medical fluoropolymers market is projected to lead the regional market in terms of revenue in 2033.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 422.3 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Medical Fluoropolymers Market Scope
Medical Fluoropolymers Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Holscot Fluoropolymers | View profile | 11-50 | Grantham, Lincolnshire, United Kingdom, Europe | https://holscot.com |
| Adtech Polymer Engineering | View profile | 11-50 | Stroud, Gloucestershire, United Kingdom, Europe | https://www.adtech.co.uk |
| The Chemours Co | View profile | 6200 | 1007 Market Street, Wilmington, DE, United States, 19801 | https://www.chemours.com |
| Dongyue Group Ltd | View profile | 6977 | Dongyue International Fluoro, Silicone Material Industry Park, Shandong Province, Zibo City, China, People's Republic of, 256401 | https://www.dongyuechem.com |
| Daikin Industries Ltd | View profile | 107127 | Umeda Center Building, 2-4-12, Nakazaki-Nishi, Kita-ku, Osaka, Japan, 530-8323 | http://www.daikin.com |
| Solvay SA | View profile | 9000 | Rue De Ransbeek, 310, Brussels, Belgium, B-1120 | https://www.solvay.com |
| Compagnie de Saint-Gobain SA | View profile | 168508 | 12, Place de l'Iris, Tour Saint-Gobain, Courbevoie, France, 92400 | http://www.saint-gobain.com |
| W.L. Gore & Associates | View profile | 5001-10000 | Newark, New Jersey, United States, North America | http://www.gore.com |
| Arkema SA | View profile | 11039 | 420 rue d’Estienne d’Orves, Colombes, France, 92700 | https://www.arkema.com |
| Hitachi Ltd | View profile | 322525 | 6-6, Marunouchi 1-chome, Chiyoda-ku, Tokyo, Japan, 100-8280 | http://www.hitachi.com |
U.S. medical fluoropolymers market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to medical fluoropolymers market will help companies and investors design strategic landscapes.
Polytetrafluoroethylene (ptfe) was the largest segment with a revenue share of 64.86% in 2024. Horizon Databook has segmented the U.S. medical fluoropolymers market based on ethylene tetrafluoroethylene (etfe), polytetrafluoroethylene (ptfe), polyvinylidene fluoride (pvdf), fluoroelastomers covering the revenue growth of each sub-segment from 2021 to 2033.
The U.S. medical fluoropolymers market is driven by the increasing demand for fluoropolymers in medical applications for manufacturing drainage bags, capsules, tablets, etc. The demand for medical fluoropolymers in various applications, including medical bags, medical tubing, catheters , and drug delivery devices, is expected to grow at a significant rate in the U.S. after the prevailing pandemic ends.
In the U.S., reduced margins and frequent increments in costs of medical products have impacted health plan formulators and healthcare service providers. This has led the Government of the U.S. to ensure a significant transformation in insurance coverage and healthcare funding in the country through the introduction of the Affordable Care Act (ACA) and Medicaid.
Key government initiatives such as Medicaid and ACA have enabled a large percentage of the population of the U.S. to gain access to healthcare facilities and services. This has led to a surged demand for medical devices, branded drugs, and healthcare services in the country, thereby driving the demand for medical fluoropolymers in the U.S. primarily utilized in medical components, as well as packaging and wound care applications.
Reasons to subscribe to U.S. medical fluoropolymers market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. medical fluoropolymers market databook
-
Our clientele includes a mix of medical fluoropolymers market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. medical fluoropolymers market , including forecasts for subscribers. This country databook contains high-level insights into U.S. medical fluoropolymers market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. medical fluoropolymers market size, by product, 2021-2033 (US$M)
U.S. Medical Fluoropolymers Market Outlook Share, 2024 & 2033 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
